Abstract IA24: Molecular imaging agents for prostate cancer: Focus on PSMA

Abstract

Abstract Although most clinical diagnostic imaging studies employ anatomic techniques such as computed tomography and magnetic resonance imaging, much of radiology research currently focuses on adapting these conventional methods to physiologic imaging as well as on introducing new techniques and probes for studying processes at the cellular and molecular levels in vivo, i.e. molecular imaging. Molecular imaging promises to provide new methods for the detection of minimal disease and support for personalized therapy. This summary will focus on experimental and near-term translational molecular imaging agents and methods for prostate cancer, with a focus on radiopharmaceuticals and optical agents, the former primarily for staging and the latter for surgical guidance. Citation Format: Martin G. Pomper. Molecular imaging agents for prostate cancer: Focus on PSMA [abstract]. In: Proceedings of the AACR Special Conference on Advances in Prostate Cancer Research; 2012 Feb 6-9; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2012;72(4 Suppl):Abstract nr IA24.